Cargando…

Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology

OBJECTIVE: Integrative oncology is widely used by patients with breast cancer. This study aims to investigate the relationship between the survival outcomes of breast cancer patients and the level of involvement in integrative oncology at the institutions treating them. METHODS: Claims-based data we...

Descripción completa

Detalles Bibliográficos
Autores principales: Crudup, Terri, Li, Linna, Dorr, Jennifer Wright, Lawson, Elizabeth, Stout, Rachel, Niknam, Pedram Vazifeh, Jones, Judi, Steen, Robert G., Casner, Susan, Lu, Lynn L., Wang, Yi, Scott, James, Zanine, Shelby, Robertshaw, Stacey, Broderick, Gabriella, Singh, Simarpreet, Lu, Jingsong, Zhou, Li, Palommella, Vaishali, Harris, Tye, Hanamirian, Michael, Reddy, Mula Shivani, Cowgill, Bruce, Rice, Jen, Nagaraja, Avinash, Jonas, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710156/
https://www.ncbi.nlm.nih.gov/pubmed/34961816
http://dx.doi.org/10.1155/2021/4746712
_version_ 1784623100167454720
author Crudup, Terri
Li, Linna
Dorr, Jennifer Wright
Lawson, Elizabeth
Stout, Rachel
Niknam, Pedram Vazifeh
Jones, Judi
Steen, Robert G.
Casner, Susan
Lu, Lynn L.
Wang, Yi
Scott, James
Zanine, Shelby
Robertshaw, Stacey
Broderick, Gabriella
Singh, Simarpreet
Lu, Jingsong
Zhou, Li
Palommella, Vaishali
Harris, Tye
Hanamirian, Michael
Reddy, Mula Shivani
Cowgill, Bruce
Rice, Jen
Nagaraja, Avinash
Jonas, Wayne
author_facet Crudup, Terri
Li, Linna
Dorr, Jennifer Wright
Lawson, Elizabeth
Stout, Rachel
Niknam, Pedram Vazifeh
Jones, Judi
Steen, Robert G.
Casner, Susan
Lu, Lynn L.
Wang, Yi
Scott, James
Zanine, Shelby
Robertshaw, Stacey
Broderick, Gabriella
Singh, Simarpreet
Lu, Jingsong
Zhou, Li
Palommella, Vaishali
Harris, Tye
Hanamirian, Michael
Reddy, Mula Shivani
Cowgill, Bruce
Rice, Jen
Nagaraja, Avinash
Jonas, Wayne
author_sort Crudup, Terri
collection PubMed
description OBJECTIVE: Integrative oncology is widely used by patients with breast cancer. This study aims to investigate the relationship between the survival outcomes of breast cancer patients and the level of involvement in integrative oncology at the institutions treating them. METHODS: Claims-based data were used to find 4,815 newly diagnosed breast cancer patients treated between January 2013 and December 2014 for survival analysis. A scoring system was developed by asking oncologists about their institutions' efforts to educate, support, and provide funding for 12 complementary and lifestyle approaches. Cohort analysis using two-tailed chi-square and a separate multivariate model using SMOTE and lasso regression were used. Nine variables across patient and institutional profiles were included. The model coefficients were exponentiated and presented as odds ratios. RESULTS: 173 patients mapped to 103 institutions and 103 oncologists. The median patient age was 51, and 8% were metastatic. Institutions were scored for integrative oncology involvement and placed into four cohorts. Low-scoring institutions showed less effort to educate, support, and provide integrative therapies compared to others. The 5-year survival of patients in the low cohort was directionally but not significantly lower than others. In the multivariate model, a composite integrative oncology score was shown to increase 5-year survival odds three times for institutions in the low-mid cohort and 48% in the mid-high, compared to the low. CONCLUSION: Crossing the threshold beyond ‘low' involvement in integrative oncology represents a new path to incremental survival benefit for many cancer patients. Entities invested in the survival of breast cancer patients should increase education, access, and funding for a core set of six therapies: nutrition counselling, exercise counselling, patient support groups, spiritual services, meditation, and psycho-oncology support.
format Online
Article
Text
id pubmed-8710156
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87101562021-12-26 Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology Crudup, Terri Li, Linna Dorr, Jennifer Wright Lawson, Elizabeth Stout, Rachel Niknam, Pedram Vazifeh Jones, Judi Steen, Robert G. Casner, Susan Lu, Lynn L. Wang, Yi Scott, James Zanine, Shelby Robertshaw, Stacey Broderick, Gabriella Singh, Simarpreet Lu, Jingsong Zhou, Li Palommella, Vaishali Harris, Tye Hanamirian, Michael Reddy, Mula Shivani Cowgill, Bruce Rice, Jen Nagaraja, Avinash Jonas, Wayne J Oncol Research Article OBJECTIVE: Integrative oncology is widely used by patients with breast cancer. This study aims to investigate the relationship between the survival outcomes of breast cancer patients and the level of involvement in integrative oncology at the institutions treating them. METHODS: Claims-based data were used to find 4,815 newly diagnosed breast cancer patients treated between January 2013 and December 2014 for survival analysis. A scoring system was developed by asking oncologists about their institutions' efforts to educate, support, and provide funding for 12 complementary and lifestyle approaches. Cohort analysis using two-tailed chi-square and a separate multivariate model using SMOTE and lasso regression were used. Nine variables across patient and institutional profiles were included. The model coefficients were exponentiated and presented as odds ratios. RESULTS: 173 patients mapped to 103 institutions and 103 oncologists. The median patient age was 51, and 8% were metastatic. Institutions were scored for integrative oncology involvement and placed into four cohorts. Low-scoring institutions showed less effort to educate, support, and provide integrative therapies compared to others. The 5-year survival of patients in the low cohort was directionally but not significantly lower than others. In the multivariate model, a composite integrative oncology score was shown to increase 5-year survival odds three times for institutions in the low-mid cohort and 48% in the mid-high, compared to the low. CONCLUSION: Crossing the threshold beyond ‘low' involvement in integrative oncology represents a new path to incremental survival benefit for many cancer patients. Entities invested in the survival of breast cancer patients should increase education, access, and funding for a core set of six therapies: nutrition counselling, exercise counselling, patient support groups, spiritual services, meditation, and psycho-oncology support. Hindawi 2021-12-18 /pmc/articles/PMC8710156/ /pubmed/34961816 http://dx.doi.org/10.1155/2021/4746712 Text en Copyright © 2021 Terri Crudup et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Crudup, Terri
Li, Linna
Dorr, Jennifer Wright
Lawson, Elizabeth
Stout, Rachel
Niknam, Pedram Vazifeh
Jones, Judi
Steen, Robert G.
Casner, Susan
Lu, Lynn L.
Wang, Yi
Scott, James
Zanine, Shelby
Robertshaw, Stacey
Broderick, Gabriella
Singh, Simarpreet
Lu, Jingsong
Zhou, Li
Palommella, Vaishali
Harris, Tye
Hanamirian, Michael
Reddy, Mula Shivani
Cowgill, Bruce
Rice, Jen
Nagaraja, Avinash
Jonas, Wayne
Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology
title Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology
title_full Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology
title_fullStr Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology
title_full_unstemmed Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology
title_short Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology
title_sort breast cancer survivorship and level of institutional involvement utilizing integrative oncology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710156/
https://www.ncbi.nlm.nih.gov/pubmed/34961816
http://dx.doi.org/10.1155/2021/4746712
work_keys_str_mv AT crudupterri breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT lilinna breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT dorrjenniferwright breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT lawsonelizabeth breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT stoutrachel breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT niknampedramvazifeh breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT jonesjudi breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT steenrobertg breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT casnersusan breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT lulynnl breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT wangyi breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT scottjames breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT zanineshelby breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT robertshawstacey breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT broderickgabriella breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT singhsimarpreet breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT lujingsong breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT zhouli breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT palommellavaishali breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT harristye breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT hanamirianmichael breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT reddymulashivani breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT cowgillbruce breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT ricejen breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT nagarajaavinash breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology
AT jonaswayne breastcancersurvivorshipandlevelofinstitutionalinvolvementutilizingintegrativeoncology